首页> 外国专利> Immortalization of human cells by the ectopic expression of human telomerase reverse transcriptase

Immortalization of human cells by the ectopic expression of human telomerase reverse transcriptase

机译:通过端粒酶逆转录酶的异位表达使细胞永生化

摘要

Immortalized primary adult and fetal human cells are provided that express a functional telomerase catalytic subunit from a nucleic acid sequence encoding the hTERT gene. The telomerase-immortalized human cells can be maintained in culture for at least 35 population doublings without developing a transformed phenotype, and while continuing to express proteins associated with the primary differentiated cell type. The invention is also directed to immortalized, non-transformed cell lines derived from primary human cells that express a functional telomerase catalytic subunit and to their use for transplantation to patients with hepatic disease. The invention also is directed to an improved biologic extracorporeal liver support device wherein the improvement is the use of telomerase-immortalized hepatocytes incorporated onto the scaffolding of the cell colonization chamber and use of the improved device for treating symptoms of patients with hepatic disease.
机译:提供了永生的原代成年和胎儿人类细胞,它们从编码hTERT基因的核酸序列表达功能性端粒酶催化亚基。端粒酶永生化的人类细胞可在培养物中维持至少35倍的种群倍增,而不会发展出转化的表型,并同时继续表达与原代分化细胞类型相关的蛋白质。本发明还涉及衍生自表达功能性端粒酶催化亚基的原代人细胞的永生化,未转化的细胞系,并涉及其用于移植到肝病患者中的用途。本发明还涉及一种改进的生物体外肝支持装置,其中所述改进是使用掺入细胞定殖室支架中的端粒酶-永生化肝细胞的用途以及该改进的装置用于治疗肝病患者的症状的用途。

著录项

  • 公开/公告号US2005123521A1

    专利类型

  • 公开/公告日2005-06-09

    原文格式PDF

  • 申请/专利权人 MARK A. ZERN;HENNING WEGE;

    申请/专利号US20040481191

  • 发明设计人 HENNING WEGE;MARK A. ZERN;

    申请日2002-06-21

  • 分类号A61K48/00;C12N5/08;C12N15/867;

  • 国家 US

  • 入库时间 2022-08-21 22:22:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号